Cargando…

Small molecules remain on target for c-Myc

Targeting the transcription factor c-Myc via one of its coactivator proteins is a promising strategy for cancer therapy.

Detalles Bibliográficos
Autores principales:	Sun, Linchong, Gao, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2017
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245958/ https://www.ncbi.nlm.nih.gov/pubmed/28100396 http://dx.doi.org/10.7554/eLife.22915

Ejemplares similares

Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2017)

Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms
por: Chan, Gary KL, et al.
Publicado: (2023)

Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc
por: Lewis, L Michelle, et al.
Publicado: (2018)

Tuning the MYC response
por: Zheng, Ying, et al.
Publicado: (2016)

Dissecting transcriptional amplification by MYC
por: Nie, Zuqin, et al.
Publicado: (2020)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)

Focal adhesion kinase activation limits efficacy of Dasatinib in c‐Myc driven hepatocellular carcinoma
por: Liu, Xianqiong, et al.
Publicado: (2018)

PTTG1 is involved in TNF‐α‐related hepatocellular carcinoma via the induction of c‐myc
por: Lin, Xianyi, et al.
Publicado: (2019)

Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c‐Myc expression
por: Wang, Xiaolong, et al.
Publicado: (2017)

Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
por: Farrell, Mariah, et al.
Publicado: (2023)

LINC01116 accelerates nasopharyngeal carcinoma progression based on its enhancement on MYC transcription activity
por: Xing, Haijie, et al.
Publicado: (2019)

Different promoter affinities account for specificity in MYC-dependent gene regulation
por: Lorenzin, Francesca, et al.
Publicado: (2016)

Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors
por: Müller, Inga, et al.
Publicado: (2014)

DNA methylation‐regulated and tumor‐suppressive roles of miR‐487b in colorectal cancer via targeting MYC, SUZ12, and KRAS
por: Chen, Xu, et al.
Publicado: (2019)

LAST, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote CCND1 mRNA stability in human cells
por: Cao, Limian, et al.
Publicado: (2017)

Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis
por: Cartwright, Ian M, et al.
Publicado: (2017)

eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis
por: Ruan, Hang, et al.
Publicado: (2020)

PHAROH lncRNA regulates Myc translation in hepatocellular carcinoma via sequestering TIAR
por: Yu, Allen T, et al.
Publicado: (2021)

Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma
por: Liu, He, et al.
Publicado: (2023)

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
por: Dhanasekaran, Renumathy, et al.
Publicado: (2020)

MAGI2‐AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR‐525‐5p/MXD1 axis
por: Chang, Hua, et al.
Publicado: (2020)

HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways
por: Miyamoto, Ryo, et al.
Publicado: (2021)

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018)

R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma
por: Overman, Jeroen, et al.
Publicado: (2019)

New small‐molecule compound Hu‐17 inhibits estrogen biosynthesis by aromatase in human ovarian granulosa cancer cells
por: Xi, Yang, et al.
Publicado: (2020)

Long non‐coding RNA ARAP1‐AS1 promotes tumorigenesis and metastasis through facilitating proto‐oncogene c‐Myc translation via dissociating PSF/PTB dimer in cervical cancer
por: Zhang, Yao, et al.
Publicado: (2020)

Mice deficient of Myc super-enhancer region reveal differential control mechanism between normal and pathological growth
por: Dave, Kashyap, et al.
Publicado: (2017)

Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
por: Suvarna, Kruthi, et al.
Publicado: (2018)

Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018)

A positive feedback loop between Myc and aerobic glycolysis sustains tumor growth in a Drosophila tumor model
por: Wong, Kenneth Kin Lam, et al.
Publicado: (2019)

MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1
por: Popay, Tessa M, et al.
Publicado: (2021)

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs
por: Wood, C David, et al.
Publicado: (2016)

A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
por: Xu, Ying, et al.
Publicado: (2022)

FOXP3 inhibits MYC expression via regulating miR‐198 and influences cell viability, proliferation and cell apoptosis in HepG2
por: Duan, Xiaohui, et al.
Publicado: (2018)

USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma
por: Ruiz, E Josue, et al.
Publicado: (2021)

Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer
por: Shi, Bin, et al.
Publicado: (2019)

MYC‐activated lncRNA HNF1A‐AS1 overexpression facilitates glioma progression via cooperating with miR‐32‐5p/SOX4 axis
por: Wu, Jianheng, et al.
Publicado: (2020)

Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC‐202 blocks oncogenic hedgehog‐GLI signaling and overcomes smoothened inhibitor resistance
por: Gruber, Wolfgang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_23nbrv561hj61e70a43sms24ne